Arkolith/Insider Trading/PSTX/Form 4

Leonhardt Harry J

GC & Chief Compliance OfficerPoseida Therapeutics, Inc. (PSTX) · full profile →Form 4 · filed Mar 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 1, 2024Grant(A)81K—$0231K
Mar 1, 2024Tax withholding(F)16K$4.13$67K215K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2024Grant(A)112K—$0112K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-024921) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML